Introduction: Obesity is a major health concern in pregnancy, and it can lead to various adverse outcomes for both the mother and the fetus. The increasing prevalence of obesity among pregnant women calls for effective strategies to prevent its occurrence and reduce its consequences. Health education and physical activity have been identified as potential interventions to prevent obesity in pregnant women. Aim of study: The aim of the review is to present the impact of physical activity and health education on obesity in pregnant women, as well as its pathogenesis and treatment.Materials and Methods: The authors followed the PRISMA guidelines to ensure high-quality work. The search was based on databases such as PubMed, Google Scholar, Scopus, and Web of Science, with a limitation to publications after. The strategy relied on search terms such as 'obesity in pregnancy', 'treatment', 'physical activity', 'health education', and 'sport', combined using 'AND' and 'OR' operators. The team members reviewed the abstracts and then decided on their inclusion in the study. Results: According to literature reviews, health education and physical activity can be effective interventions in preventing obesity in pregnant women. They can help prevent excessive weight gain during pregnancy and reduce the risk of gestational diabetes and other obesity-related complications. Individual dietary advice, exercise programs, and lifestyle modification counseling are recommended. However, further research is needed to determine the most effective strategies for preventing obesity in pregnant women and assessing long-term health outcomes.Conclusions: Both regular physical activity and health education can be useful in prevention and treatment of obesity during pregnancy, and should be included as part of a comprehensive approach to women's health during pregnancy. It is important for people to understand the benefits of regular physical activity throughout the entire pregnancy period.

Introduction Aesthetic medicine procedures significantly affect the comfort of patient's lives, their amount of physical activity and mental health. Today, medicine serves not only to eliminate the consequences of diseases or their prevention, but also aesthetic considerations, which are directly related to the quality of life in general. Purpose The purpose of this review is to present the current state of knowledge on the impact of aesthetic medicine procedures on the comfort of patients' lives.  Methods Literature was searched in PubMed and Google Scholarship databases. Publicly available books were searched. Results  People who use aesthetic medicine can improve their self-esteem and even their socioeconomic status or get a better job than before. Conclusions Patients’s quality of life and mental health significantly increase after aesthetic medicine procedures.

Introduction and purpose: Sudden cardiac death (SCD) is a rare condition, however it is the leading medical cause of death in population of athletes. This study reviews the epidemiology and common causes of SCD in this group. The literature on the role of pre-participation screening and of the other preventive measures was also reviewed. Review methods: A review of the available literature on sudden cardiac death in athletes was conducted using PubMed and Google Scholar databases. Description of the state of knowledge: SCD is the leading cause of death in athletes. However, the incidence is difficult to estimate and varies in different populations. The etiology is age-dependent, in young individuals the most common cause of sudden cardiac death are hypertrophic cardiomyopathy and congenital coronary artery anomalies. In the older athlete population (over 35 years old) atherosclerotic coronary artery disease is the main cause. Screening process varies between countries and besides taking the medical history and physical examination can involve electrocardiogram, echocardiography and other examinations. Conclusions: A review of the following studies has shown, that pre-participation screening of athletes may help to reduce the incidence of sudden death. Equal focus should be put on the availability of medical facilities during sports events, including experienced medical team and access to automated external defibrillation.

IntroductionThe most common pаthologicаl condition аssociаted with gout is hypertension (HT). The mаin orgаn responsible for this process is the kidneys. The development of chronic tubulointerstitiаl nephritis in the course of gout leаds to ischemiа of the renаl pаrenchymа, аctivаtion of the renin-аngiotensin-аldosterone system (RааS), sodium аnd wаter retention in the body, which leаds to the development of hypertension. The kidneys, on the other hаnd, аre responsible for the metаbolism аnd excretion of uric аcid from the body, so their dаmаge аccordingly leаds to the deteriorаtion of this process. In pаtients with gout, the level of uric аcid determines the severity of gouty аrthritis, dаmаge to blood vessels аnd joints. Therefore, it is extremely importаnt to know the specifics of uric аcid metаbolism in pаtients with gout, since the effectiveness of the prescribed hypouricemic therаpy depends on it. Aim of the studyThe аim of the study wаs to аnаlyze the metаbolism of uric аcid in pаtients with gout аnd concomitаnt аrteriаl hypertension, аnd to determine the impаct of concomitаnt metаbolic disorders on the excretory function of the kidneys. ConclusionThe results of the conducted reseаrch prove thаt: 1. Pаtients with gout with concomitаnt hypertension hаve more pronounced metаbolic disorders thаn pаtients with gout without hypertension. This is mаnifested by impаired cаrbohydrаte tolerаnce, аn increаse in totаl cholesterol, triglycerides аnd а decreаse in HDL levels.2. Pаtients with gout аnd hypertension hаve deeper renаl dysfunction, which is mаnifested by а tendency to decreаse GFR аnd increаse creаtinine levels compаred to pаtients with gout without hypertensive syndrome.3. Violаtion of uric аcid metаbolism in pаtients with gout аnd аrteriаl hypertension is mаnifested by аn increаse in the reаbsorption process аnd а decreаse in the filtrаtion process of uric аcid, which results in higher rаtes of uricemiа.

Introduction: Human plasma contains valuable proteins such as albumin, globulins and coagulation factors. These ingredients are used to obtain medicinal products (PDMPs - plasma-derived medicinal products) used in many fields of medicine. The growing number of indications for their use causes an increase in the demand for plasma collected from blood donors. Most donors, however, choose to donate whole blood, which provides a lower amount of plasma than plasmapheresis. Purpose of the study: This study aims to indicate the reasons why donors do not decide to donate plasma by apheresis, to show the role of informing donors about the plasmapheresis, about the uses of plasma collected and about the safety of the process. The work also presents examples of PDMPs applications that can be used in the process of educating donors, which may contribute to increasing the number of plasma donors and, at the same time, the availability of PDMPs. Material and methods: A review of scientific research (using Pubmed, Google Scholar databases), medical books and materials published on websites of institutions related to blood donation regulations was conducted. Results: The reasons why blood donors do not decide to donate plasma include, among others, longer donation time and lack of knowledge about plasmapheresis. The decision to donate plasma via plasmapheresis is influenced not only by the fact of informing the donor about such a possibility, but also by the content and manner of providing the information. Due to the greater amount of plasma obtained each time by plasmapheresis compared to the separation of whole blood, an increase in the number of donors undergoing plasmapheresis may indirectly positively affect the availability of plasma-derived medicinal products